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Abstract
Background: Excess weight in adulthood is one of the few modiﬁable risk factors for pancreatic
cancer, and height has associations as well. This leads to the question of whether body weight and
height in childhood are associated with adult pancreatic cancer.
Objective: The aim of the study was to examine if childhood body mass index (BMI; kg/m2) and
height are associated with pancreatic cancer in adulthood.
Methods: We linked 293,208 children born from 1930 to 1982 in the Copenhagen School Health
Records Register who hadmeasured values of weights and heights at ages 7–13 y with the Danish
Cancer Registry to identify incident pancreatic cancer cases from 1968 to 2012. HRs and 95% CIs
were estimated by using Cox proportional hazards regressions.
Results: During 8,207,015 person-years of follow-up, 1268 pancreatic cancer cases were
diagnosed. Childhood BMI z scores at ages 7–13 y were positively and signiﬁcantly associated
with pancreatic cancer in men and women ,70 y of age; $70 y of age, the associations
diminished. The HRs of pancreatic cancer were 1.13 (95% CI: 1.05, 1.21) and 1.18 (95% CI: 1.09,
1.27) according to BMI z score at ages 7 and 13 y, respectively. A BMI z score of $1.5 at ages 7,
10, and 13 y was positively and signiﬁcantly associated with pancreatic cancer; however, the effect
did not differ from having a BMI z score $1.5 at only one of these ages. Positive, albeit
nonsigniﬁcant, associations were identiﬁed with height.
Conclusions: BMI at all ages from 7 to 13 y was positively and linearly associated with adult
pancreatic cancer: the higher the BMI, the higher the risk. Excess childhood BMImay be indicative
of processes initiated early in life that lead to this cancer. The prevention of childhood adiposity
may decrease the burden of pancreatic cancer in adults. Curr Dev Nutr 2017;1:e001362.
Introduction
Pancreatic cancer is the fourth leading cause of cancer death in the United States (1), and it
ranks in the top 10 leading causes of cancer death in Denmark (2). Pancreatic cancer is highly
fatal; 65% of patients die within 1 y of diagnosis and the current 5-y survival rate is 7.7% (3).
Although overall cancer incidence and deaths are declining, incidence and death rates for
pancreatic cancer have increased (1). One hypothesis that may explain these increasing rates
is the current obesity and diabetes epidemic.
Adult obesity has emerged as a consistent risk factor for pancreatic cancer over the past
decade (4–10). Current studies have shown overweight and obesity during late adoles-
cence and early adulthood to be associated with an elevated risk of this disease (9–12). Ev-
idence also suggests that there is a cumulative eﬀect of adult overweight: the longer an
adult is overweight or obese, the greater the risk of pancreatic cancer (12). Furthermore,
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as with many forms of cancer, a greater adult attained height is
also associated with increased pancreatic cancer risk, but the ex-
act mechanisms remain speculative (4, 13).
Childhood obesity is a global public health issue, with an esti-
mated 155 million school-aged children currently classiﬁed as
overweight or obese (14). Overweight and obesity in childhood
are associated with a variety of diseases in adulthood (9, 11, 12,
15–18). The World Cancer Research Fund reported greater child-
hood growth as a probable risk factor for pancreatic cancer; how-
ever, this was based on attained height and BMI during early
adulthood (4). The majority of the studies that examined body
size during adolescence or early adulthood relied on recalled
weight and height (9, 11, 12). Hence, we examined whether child-
hood BMI and height as determined from measures during child-
hood health examinations are associated with subsequent
pancreatic cancer in adulthood in a Danish population.
Methods
Study population
In this prospective cohort study, 372,636 individuals from the Co-
penhagen School Health Records Register who were born from
1930 to 1989 underwent mandatory health examinations at public
and private schools from ages 7 to 13 y annually through 1983, after
which time the health examinations were performed only at school
entry and exit unless a child had special health needs (19). During
the examinations, school doctors and nurses measured the height
and weight of the children by using equipment provided by the
schools and standard procedures. Each child was assigned a health
card with the child’s name, year of birth, height, and weight. This
information has been computerized. The Copenhagen School
Health Records Register was built in collaboration between the De-
partment of Clinical Epidemiology (formerly the Institute of Preven-
tive Medicine) and the Copenhagen City Archives in Denmark.
A unique personal identiﬁcation number was assigned to all
Danish residents who were alive or born after April 1968, when
the Central Person Register was established (20). Children who
were in school at that time or later had their identiﬁcation number
recorded on their health cards, and children who attended school
before this time had their identiﬁcation numbers retrieved from
the register on the basis of their name and date of birth (21). These
numbers were identiﬁed for .88% of the children in the register.
The process of retrieving the numbers was conservative (19), and
the main reasons for not identifying the number were death, em-
igration before 1968, or misspellings in names that precluded the
unique identiﬁcation of the child.
BMI was calculated by dividing weight in kilograms by height
in meters squared. BMI values were transformed to z scores on the
basis of an internal age- and sex-speciﬁc reference that was com-
puted by using the Lambda Median Sigma method (22). The ref-
erence population was chosen from a period when the
prevalence of obesity was low and stable, and z scores were inter-
polated to the exact age if 2 measurements were available or ex-
trapolated if only 1 measurement was available, but always
within a 612-mo time frame (15).
The identiﬁcation number enabled linkage to the Danish Can-
cer Registry (23) from which information on pancreatic cancer
was obtained. The cancer registry has collected information on
all cancer diagnoses in Denmark since 1943. Pancreatic cancer
was deﬁned according to the modiﬁed Danish version of the Inter-
national Classiﬁcation of Diseases versions 7 (code 157.0) and 10
(codes C25.0–C25.4, C25.7–C25.9).
The ﬁrst diagnosis of pancreatic cancer, regardless of a previ-
ous cancer diagnosis, was used in the analyses. Follow-up began
in 1968, corresponding to when the computerized vital statistics
register was established. We followed individuals from 30 y of
age, corresponding to the birth years of 1930–1982. From the pop-
ulation of 348,974 individuals available for this study, 42,480 did
not have a personal identiﬁcation number; and from the remaining
individuals with identiﬁcation numbers, 2309 died, 6281 emi-
grated, and 196 were lost to follow-up before the age of 30 y (Sup-
plemental Figure 1). Therefore, the eligible population for
inclusion in the study consisted of 297,708 individuals who were
alive and living in Denmark at 30 y of age. Exclusions were
made for individuals who had pancreatic cancer before 30 y of
age (n = 1) and individuals with missing (n = 4492) or outlying (z
scores ,24.5 or .4.5) height or BMI values at all ages (n = 7)
(Supplemental Figure 1). Of the 293,208 individuals included in
the study, 6152 individuals emigrated, 166 individuals were lost
to follow-up, and 56,147 died before the end of the study period.
Follow-up ended on the date of a pancreatic cancer diagnosis,
death, emigration, or 31 December 2013, whichever came ﬁrst.
The analyses were conducted on anonymous data, and the
study was approved by the Danish Data Protection agency. Ac-
cording to the Danish Act of Processing of Personal Data, in-
formed consent is not required for register-based research of
pre-existing personal data.
Statistical analyses
Associations between BMI and height z scores at each age from 7 to
13 y were estimated by using Cox proportional hazards regression
models with age as the underlying time metric. We conducted the
sensitivity analyses adjusting BMI for height, and vice versa, because
they are correlated in childhood. To examine if there was a cumula-
tive eﬀect of excess BMI in childhood, we examined if children who
were heavy, deﬁned as having a BMI z score$1.5 (equivalent to the
93.3rd percentile), at ages 7, 10, and/or 13 y had a diﬀerent risk of
pancreatic cancer than did children who had a BMI z score ,1.5
at these ages. Due to how the z scores were calculated, the ages of
7, 10, and 13 were chosen for analysis because they were calculated
independently of each other. Children who never had a BMI z score
$1.5 at any of these ages formed the reference group. Furthermore,
we examined if children whowere heavier at age 13 y irrespective of
their body size history had a diﬀerent risk of pancreatic cancer than
children who were not large at age 13 y. For these analyses, the ref-
erence group was children with a BMI z score,1.5 at age 13 y only.
Because the cohort spans many years of birth, all of the analy-
ses were stratiﬁed by birth cohort (5-y intervals from 1930–1975 to
1976–1982). Interactions of BMI and height z-score associations
with pancreatic cancer by sex and birth cohort were also tested
by using log likelihood ratio tests. No interactions were detected
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(all P. 0.40); however, because the sex-speciﬁc results may be of
interest, these are presented as well. The linearity of the associa-
tions was assessed by restricted cubic splines (5 knots), and nota-
ble violations were not detected. The proportional hazards
assumption was tested in each model by the inclusion of a time-
varying eﬀect of BMI and height, respectively, in the Cox regres-
sion models. Violations were detected such that the associations
with BMI changed at ;70 y of age (P-value range: 0.005–0.035).
Therefore, we present analyses stratiﬁed by,70 and$70 y of age.
We calculated the unadjusted population attributable fraction
(PAF) (24) to estimate the percentage of pancreatic cancer cases
before age 70 y that would potentially be eliminated if children
were not overweight or obese at age 13 y. Overweight and obesity
were deﬁned by using the CDC 2000 classiﬁcations (25). For these
calculations, we used the HRs for boys and girls at age 13 y in our
Danish study population and the proportions of overweight or
obese girls and boys at age 12.5– 13.5 y in the US NHANES (all eth-
nicities) between 2003 and 2014 (26).
Results
At least 1 BMI and height z score were available for 144,826 girls and
148,382 boys. As previously published and expected, height and BMI
increased with age in this study population (18). The analyses in-
cluded 8,207,015 person-years of follow-up after age 30 y. During
follow-up there were 1268 cases of pancreatic cancer (699 in men
and 569 in women). The incidence of pancreatic cancer increased
with advancing age and was slightly higher in the men than in
women (Figure 1).
Positive and signiﬁcant associations between childhood BMI z
scores and adult pancreatic cancer were found at all ages (Supple-
mental Table 1, Figure 2). Childhood BMI z scores at each age
from 7 to 13 y were signiﬁcantly associated with pancreatic cancer
risk in men and women up until the age of 70 y (Supplemental Ta-
ble 1, Figure 2). Beyond 70 y of age, the associations were no longer
signiﬁcant. No notable violations of linearity were detected; the
pancreatic cancer risk was greatest with the highest childhood
BMI z scores. Adjustment for height in the model had no eﬀect
on HRs of pancreatic cancer (Supplemental Table 2). Height
was positively, albeit nonsigniﬁcantly, associated with adult pan-
creatic cancer (Table 1).
In the subanalysis of 119,799 men and 119,080 women who had
BMI values at 7, 10, and 13 y of age, we examined if there was an
eﬀect of repeatedly high BMI or if it was only size at 13 y that mat-
tered for later pancreatic cancer. Compared with the reference
group of children who had BMI z scores ,1.5 at all ages of 7, 10,
and 13 y, having a BMI z score of $1.5 once, twice, or 3 times at
any of these ages (7, 10, or 13 y) was associated with an increased
risk of pancreatic cancer until age 70 y (Table 2). Even though the
HRs for children who had a BMI z score $1.5 at all 3 ages were
higher than for other combinations of BMI z scores, these diﬀer-
ences were not signiﬁcant compared with having a z score .1.5 at
only 1 age (P = 0.88) or at 2 ages (P = 0.67). Compared with the ref-
erence group of 225,606 children with a BMI z score ,1.5 at age
13 y (823 pancreatic cancer cases), the 13,273 children who had
a BMI z score $1.5 at the same age (61 pancreatic cancer cases)
had an HR for pancreatic cancer ,70 y of 1.51 (95% CI: 1.16, 1.96).
With the use of the pooled data from NHANES and the CDC
criteria, among 13-y-old US children, 14.8% of boys and 17.2% of
girls are classiﬁed as overweight and 21.7% of boys and 21.5% of
girls are classiﬁed as obese. On the basis of these US prevalence
data and the pancreatic cancer HRs for BMI at age 13 y from
the continuous model from our Danish study, we estimated that
the PAFs of pancreatic cancer before age 70 y will be 12.7% and
11.4% for men and women, respectively.
Discussion
In this large, prospective, population-based study that used mea-
sured heights and weights in childhood, we found that BMI at
each age from 7 to 13 y was signiﬁcantly and positively associated
with pancreatic cancer in adulthood diagnosed up until age 70 y; be-
yond this age, there were no associations. Repeatedly having a high
BMI at ages 7, 10, and 13 ywas not signiﬁcantly diﬀerent from having
a high BMI 1 time. Associations were similar for men and women
FIGURE 1 Incidence of pancreatic cancer among men and women
from 30 to 83 y of age.
FIGURE 2 Childhood BMI z score and pancreatic cancer risk by
diagnosis at ages,70 and$70 y. The dashed line represents an HR
of 1. Analyses were stratiﬁed by sex and birth cohort.
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and consistent for cancer diagnosis from 30 to 70 y of age. Associa-
tions between child height and pancreatic cancer, although positive,
were not signiﬁcant.We think our study is novel because it examines
child body size in relation to the risk of pancreatic cancer in adult-
hood and other investigations focused on body size at older ages.
Our ﬁndings are consistent with previous studies that exam-
ined adolescent or early adulthood BMI and pancreatic cancer
(11, 27). Within a cohort of 720,000 Israeli men with BMI mea-
sured at ages 16–19 y, adolescent overweight as deﬁned by a
BMI z score.1, compared with a z score$21 to#1, showed a sig-
niﬁcant 2-fold increase in pancreatic cancer risk (27). One case-
control study found a signiﬁcant increase in risk associated with
a 5-unit increase in recalled BMI during adolescence and early
adulthood (11). The American NIH-AARP Diet and Health Study
Cohort (NIH-AARP) and 2 pooled analyses of cohort studies
showed adolescent or early adulthood body size obtained by recall
to be positively associated with pancreatic cancer (8, 9, 11). The as-
sociations were independent of BMI at an older age, suggesting
that the risk was established to a certain extent in earlier life. In
a study in American retired adults (50–71 y of age) in the NIH-
AARP, adolescent body size obtained by recall had a positive asso-
ciation with pancreatic cancer (12). The eﬀect was not attenuated
by including adult size, thus suggesting that the risk was estab-
lished to a certain extent in earlier life. Because adult body size
was not available in the current study, we could not conduct a fully
comparable analysis. When BMI was analyzed as a continuous
variable by using recalled height and weight at age 50 y from
participants in the NIH-AARP study, the HRs for the association
between BMI and pancreatic cancer were 1.18 (95% CI: 1.07,
1.32) for men and 1.02 (95% CI: 0.94, 1.12) for women per z score
(R Stolzenberg-Solomon, M Gamborg, unpublished data, 2016). In-
terestingly, these associations were of a smaller magnitude than
those observed in the current study per BMI z score, which suggests
that tracking of childhood BMI whereby heavy children become
heavy adults is not the only explanation for the observed results.
Prospective studies have also shown that BMI gain during
adulthood and after age 50 y is associated with an elevated risk
of pancreatic cancer (9, 10, 12). Given that we did not observe
an association between childhood BMI and pancreatic cancer di-
agnosed after age 70 y, it is possible that childhood adiposity con-
tributes to pancreatic cancer diagnosed at younger ages, whereas
adiposity related to weight gain during adulthood contributes
more to occurrence of cancer diagnosis later at older ages.
Our results suggest that there is not a cumulative eﬀect of ex-
cess adiposity during childhood associated with adult pancreatic
cancer. In our study, the association between having a high BMI
value.1 time from the ages of 7 to 13 y and subsequent pancreatic
cancer did not diﬀer signiﬁcantly from the association observed
for having a high BMI only 1 time (Table 2). In contrast, the
NIH-AARP study showed that longer absolute and cumulative
years of being overweight or obese [BMI (kg/m2)$25.0] were sig-
niﬁcantly associated with pancreatic cancer (12). It is possible that
we examined too few years during childhood to detect a cumula-
tive eﬀect, that we had too few cases to distinguish such patterns,
TABLE 1 Childhood height z scores at ages 7–13 y and pancreatic cancer risk in adulthood1
Age, y
Age at diagnosis
<70 y ‡70 y
Individuals, n Cases, n HR (95% CI) Individuals, n Cases, n HR (95% CI)
7 275,525 922 1.03 (0.96, 1.10) 58,475 264 1.10 (0.97, 1.24)
8 279,796 928 1.04 (0.97, 1.11) 59,813 270 1.10 (0.97, 1.24)
9 273,388 930 1.04 (0.97, 1.11) 59,989 275 1.11 (0.98, 1.25)
10 267,867 930 1.03 (0.97, 1.10) 60,015 275 1.10 (0.97, 1.24)
11 266,091 922 1.04 (0.98, 1.11) 60,128 278 1.09 (0.96, 1.22)
12 263,328 929 1.04 (0.97, 1.11) 59,898 271 1.07 (0.95, 1.21)
13 259,342 927 1.05 (0.99, 1.13) 59,043 264 1.09 (0.96, 1.23)
1Analyses were stratiﬁed by sex and birth cohort.
TABLE 2 Patterns of repeatedly high BMI values ($1.5 z score) at ages 7, 10, and 13 y and pancreatic cancer risk in adulthood by
age at diagnosis1
BMI z
score ‡1.5
Age at diagnosis
<70 y ‡70 y
Individuals, n Cases, n HR (95% CI) Individuals, n Cases, n HR (95% CI)
Never 217,721 789 Reference 50,105 224 Reference
Age 7 y only 3839 17 1.32 (0.82, 2.13) 753 3 0.93 (0.30, 2.91)
Age 10 y only 2131 11 1.51 (0.83, 2.75) 369 2 1.52 (0.38, 6.12)
Age 13 y only 4243 21 1.54 (1.00, 2.37) 703 4 1.50 (0.56, 4.03)
Ages 7 and 10 y 1915 6 1.04 (0.46, 2.32) 255 1 1.05 (0.15, 7.46)
Ages 7 and 13 y 830 3 1.20 (0.39, 3.72) 131 0 —
Ages 10 and 13 y 2996 13 1.34 (0.78, 2.32) 481 0 —
Ages 7, 10, and 13 y 5204 24 1.70 (1.13, 2.56) 566 1 0.47 (0.67, 3.33)
1Analyses were stratiﬁed by sex and birth cohort. Compared with a child with a BMI z score $1.5 at 7, 10, and 13 y, the HR did not signiﬁcantly differ from children who
had a BMI z score $1.5 at only 1 age (P = 0.88) or at 2 ages (P = 0.67).
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or that it is body size change across many years during mid- to late
adult life that is important for pancreatic cancer development.
Despite evidence from several studies that suggests that adult
height has a positive association with pancreatic cancer (4, 13),
there is great heterogeneity in the literature, with later reports
pointing toward the association being very modest in magnitude
(28). In our study, the HRs for the associations between childhood
height and pancreatic cancer were positive, but weak and not sig-
niﬁcant. Given that the CIs around the estimates were small, it is
unlikely that our study was underpowered to detect an eﬀect, but
this cannot be ruled out. Nonetheless, our ﬁndings are in accord
with the majority of the adult literature.
BMI is not a perfect indicator of adiposity in either adults or
children. In childhood, it is correlated with height, and this re-
ﬂects that the body composition of healthy tall children has a
greater amount of lean and adipose tissue (29). However, even
when we accounted for the eﬀects of height beyond what is cap-
tured by BMI in the models, the associations between childhood
BMI and pancreatic cancer remained virtually unchanged. These
results suggest that some aspect of body composition, presum-
ably the adipose tissue component, is contributing to our ob-
served associations. Adipose tissue is an endocrinologically
active tissue that is known to be linked to pancreatic inﬂamma-
tion, b cell dysfunction, insulin resistance, and diabetes (30).
These processes have been suggested to play an etiologic role
in adulthood pancreatic cancer (31) and may likewise contribute
to our association between childhood BMI and pancreatic can-
cer. Excess childhood weight may also be linked to later pancre-
atic cancer through correlations between child and adult size or
through independent processes that stimulate early steps of car-
cinogenesis. Genes involved in the embryonic development of
pancreas have been associated with BMI, diabetes, as well as
pancreatic adenocarcinoma (32–34), which lends support to
early-life exposures that aﬀect the pancreas having a role in
the pathways that lead to the development of pancreatic cancer
later in life. Future research is warranted to determine whether
the association between childhood excess weight and risk of pan-
creatic cancer later in life is mediated through adult adiposity
and to understand the biological mechanisms that explain the as-
sociations that we observed.
Several strengths of our study should be noted, including the
prospective design and the availability of measured, instead of re-
called, height and weight during childhood. Furthermore, selec-
tion bias is unlikely to be present in our study, because it
included virtually all children born from 1930 to 1982 who at-
tended school in Copenhagen and we were able to follow these in-
dividuals from 1977 onward with the Danish registers. Pancreatic
cancer diagnoses were obtained from the Danish Cancer Registry,
which has a high coverage due to the mandatory reporting of all
malignant neoplasms. In Denmark, health care is universal and
paid for by taxation, so it is unlikely that this study is aﬀected by
access bias. Furthermore, there was minimal loss to follow-up be-
cause all subjects could be eﬃciently tracked through the Danish
registry system. Information on family history of pancreatic can-
cer, childhood diet and second-hand smoke exposure, adult body
size, and other adult health conditions (e.g., diabetes and
pancreatitis) and exposures (e.g., adult smoking history) was not
available. Exposures in adulthood, however, are unlikely con-
founders of measured childhood height and weight. Furthermore,
some of these factors may be mediating factors on the causal path-
way from obesity and pancreatic cancer. There may also be other
unknown exogenous exposures as well as genetic susceptibility
(35) contributing to the pancreatic cancer associations that we ob-
served that cannot be controlled for in our present analysis. Our
Danish population was primarily white, and our results might
not be generalizable to other ethnicities. Nonetheless, our results
along with those of others suggest that childhood BMI is associ-
ated with future pancreatic cancer and that body size across the
life span contributes to this disease (8, 9, 11).
Childhood overweight and obesity in children have increased in
Denmark (36) and across the globe (14). Our results show that risks
are signiﬁcantly elevated even at BMI z scores of 1.0 (84.1 percen-
tile) in our study population. For example, when compared with
the contemporary US reference for 13-y-old children, our BMI z
scores of 1.0 (BMI of 20.9 in girls and 20.3 in boys) are equivalent
to BMI values that fall just below the 75th percentiles. Thus, ele-
vated risks are being observed at BMI values far below those that
are currently classiﬁed as “overweight” by the CDC reference. To
place our results in perspective, we calculated PAFs by using the
prevalence of overweight and obesity in contemporary American
children (.36% among 13-y-old boys and girls). If contemporary
children moved from being overweight (including obesity) to nor-
mal weight at age 13 y, 12.7% and 11.4% of cases of pancreatic cancer
before age 70 y might be avoided among men and women, respec-
tively. These estimations, even with the limitations of their assump-
tions of causality, underscore that there is cause for concern about
the future risk of pancreatic cancer in children of today.
In conclusion, we found that childhood BMI has a strong and
positive association with pancreatic cancer in adulthood before
age 70 y. The association between having a high childhood BMI
repeatedly during the ages 7–13 y and pancreatic cancer did not
signiﬁcantly diﬀer from having a high BMI at only one age during
this age period. Associations between child height and pancreatic
cancer were not signiﬁcant. These results support the hypothesis
that excess BMI in childhood contributes to the future risk of pan-
creatic cancer before 70 y of age.
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